A DNA damage checkpoint drives phenotypic transition in cardiomyopathy
Hypertrophic cardiomyopathy (HCM) arises from sarcomeric gene mutations, yet the mechanisms determining whether hypertrophic remodelling remains compensated or progresses to heart failure remain unresolved. Although energetic demand and oxidative stress are increased in HCM, whether these changes reflect metaboli...